Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1346773-63-4

Post Buying Request

1346773-63-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1346773-63-4 Usage

Description

(R)-tert-butyl 5-oxopyrrolidin-3-ylcarbaMate, a carbamate derivative of pyrrolidine with the molecular formula C11H19NO3, is a heterocyclic organic compound that exists as an enantiomer of tert-butyl 5-oxopyrrolidin-3-ylcarbamate. It is recognized for its role as a building block in organic synthesis, particularly in the pharmaceutical and agrochemical industries, where it serves as a key intermediate in the production of biologically active compounds. The tert-butyl group enhances its stability and selectivity in chemical reactions, making it an indispensable tool in the development of innovative pharmaceuticals and agrochemicals.

Uses

Used in Pharmaceutical Industry:
(R)-tert-butyl 5-oxopyrrolidin-3-ylcarbaMate is used as a key intermediate for the synthesis of various biologically active compounds. Its unique structure and the presence of the tert-butyl group contribute to the development of new pharmaceuticals with enhanced stability and selectivity in their intended applications.
Used in Agrochemical Industry:
In the agrochemical sector, (R)-tert-butyl 5-oxopyrrolidin-3-ylcarbaMate is utilized as a crucial building block in the creation of agrochemicals. Its role in organic synthesis allows for the production of compounds that can be used in pest control, crop protection, and other agricultural applications, ensuring the development of effective and stable agrochemical products.
Used in Organic Synthesis:
(R)-tert-butyl 5-oxopyrrolidin-3-ylcarbaMate is employed as a versatile building block in organic synthesis, allowing for the creation of a wide range of chemical compounds. Its unique properties and reactivity make it a valuable component in the synthesis of complex organic molecules for various applications across different industries.

Check Digit Verification of cas no

The CAS Registry Mumber 1346773-63-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,7,7 and 3 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1346773-63:
(9*1)+(8*3)+(7*4)+(6*6)+(5*7)+(4*7)+(3*3)+(2*6)+(1*3)=184
184 % 10 = 4
So 1346773-63-4 is a valid CAS Registry Number.

1346773-63-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-[(3R)-5-oxopyrrolidin-3-yl]carbamate

1.2 Other means of identification

Product number -
Other names (R)-tert-Butyl (5-oxopyrrolidin-3-yl)carbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1346773-63-4 SDS

1346773-63-4Relevant articles and documents

POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC M2 RECEPTOR

-

Paragraph 1328-1330, (2018/11/21)

The present application relates to positive allosteric modulators of the muscarinic M2 receptor, especially to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of cardiovascular disorders and/or renal disorders.

NEW HETEROCYCLIC AMIDE COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

-

Page 45-46, (2010/11/30)

The present invention relates to novel heterocyclic compounds that inhibit phosphodiesterase type 4 (PDE 4). The compounds are useful for treating inflammatory conditions, diseases of the central nervous systems and insulin resistant diabetes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1346773-63-4